Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
PolarityTE, Inc. - Common Stock
(NQ:
PTE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PolarityTE, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 28, 2021
From
The Schall Law Firm
Via
Business Wire
POLARITYTE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against PolarityTE, Inc. and Encourages Investors to Contact the Firm
September 27, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 27, 2021
From
The Schall Law Firm
Via
Business Wire
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages PolarityTE, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PTE
September 27, 2021
From
Rosen Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 21, 2021
Gainers Viridian Therapeutics (NASDAQ:VRDN) shares rose 18.05% to $12.62 during Tuesday's pre-market session. The company's market cap stands at $120.9 million....
Via
Benzinga
PolarityTE, Inc. (NASDAQ:PTE) Investor Alert: Investigation over Possible Violations of Securities Laws
September 09, 2021
San Diego, CA -- (SBWIRE) -- 09/09/2021 -- An investigation over potential securities laws violations by PolarityTE, Inc. in connection with certain financial statements was announced.
Via
SBWire
Exposures
Product Safety
PolarityTE to Attend H.C. Wainwright 23rd Annual Global Investment Conference and 2021 Cantor Virtual Global Healthcare Conference
September 07, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE Appoints Richard Hague as Chief Executive Officer and Elects David Seaburg to Board of Directors and Chair of Strategic Review Committee
September 02, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE Stock Drops On FDA Clinical Hold On SkinTE Trial Application
August 24, 2021
The FDA has issued a clinical hold on PolarityTE Inc's (NASDAQ: PTE) SkinTE Investigational New Drug Application (IND) for chronic cutaneous ulcers. The...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 24, 2021
Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is...
Via
Benzinga
PTE Stock: The FDA News That Has Biotech Penny Stock PolarityTE Plunging Today
August 24, 2021
PolarityTE (PTE) stock is taking a beating on Tuesday after the biotechnology company got an update from the FDA on its IND.
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 24, 2021
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
PolarityTE Provides Update on U.S. FDA Investigational New Drug Application for SkinTE®
August 24, 2021
From
PolarityTE, Inc.
Via
Business Wire
30 Stocks Moving in Friday's Pre-Market Session
August 13, 2021
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.9% to $0.839 in pre-market trading after the company reported better-than-expected Q2 sales. The company said it continues to...
Via
Benzinga
PolarityTE Reports Second Quarter Financial Results and Provides Business Update
August 12, 2021
From
PolarityTE, Inc.
Via
Business Wire
Earnings Scheduled For August 12, 2021
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
PolarityTE to Report Second Quarter Financial Results on August 12, 2021
July 29, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE's SkinTE Meets Primary, Secondary Endpoint Goals In Diabetic Foot Ulcer Trial
July 28, 2021
PolarityTE Inc (NASDAQ: PTE) has announced final data from a trial evaluating SkinTE plus standard of care (SOC) vs. SOC alone for Diabetic Foot Ulcers. The trial...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 28, 2021
Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial
July 28, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers
July 26, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE Issues Statement About Potential Ticker Symbol Confusion
July 16, 2021
From
PolarityTE, Inc.
Via
Business Wire
PolarityTE Receives Notice of Allowance for Chinese Patent
July 12, 2021
From
PolarityTE, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 27, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
60 Biggest Movers From Yesterday
May 21, 2021
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
May 20, 2021
Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 20, 2021
Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.